BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Stemcells Inc.

Headquarters: Newark, CA, United States
Website: N/A
Year Founded: 1988
Status: Merged

BioCentury | Aug 9, 2019
Finance

Stem cells (re)generate rewards for Versant, Bayer

A risky bet on BlueRock’s stem cell technology has paid off for Versant and Bayer
BioCentury | Dec 22, 2016
Finance

Starting up stem cells

How Bayer and Versant are betting on iPS cell therapies with BlueRock startup
BioCentury | Nov 4, 2016
Strategy

The next (re)generation

Why investors both want and worry about regenerative medicine
BioCentury | Oct 4, 2016
Company News

Management tracks

BioCentury | Jul 11, 2016
Clinical News

Human neural stem cells: Phase II discontinued

BioCentury | Jul 11, 2016
Finance

Shedding red

Biotech winners, losers in 2Q16
BioCentury | Jun 13, 2016
Financial News

StemCells withdraws rights offering

BioCentury | Mar 21, 2016
Financial News

StemCells completes follow-on

BioCentury | Jan 4, 2016
Company News

StemCells neurology, gene/cell therapy news

BioCentury | Nov 23, 2015
Clinical News

Human neural stem cells: Interim Phase II data

Items per page:
1 - 10 of 160
Help Center
Username
Request Training
Submit Data Correction
Ask a Question